Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Ectoin lozenges on oropharyngeal allergic symptoms.
Khachouk R, Pieper-Fürst U, Acikel C, Kolot C, Bilstein A, Mösges R. Khachouk R, et al. Among authors: mosges r. Clin Transl Allergy. 2022 Jan 6;12(1):e12095. doi: 10.1002/clt2.12095. eCollection 2022 Jan. Clin Transl Allergy. 2022. PMID: 35028129 Free PMC article. No abstract available.
Efficacy and tolerability of an ectoine mouth and throat spray compared with those of saline lozenges in the treatment of acute pharyngitis and/or laryngitis: a prospective, controlled, observational clinical trial.
Müller D, Lindemann T, Shah-Hosseini K, Scherner O, Knop M, Bilstein A, Mösges R. Müller D, et al. Among authors: mosges r. Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2591-7. doi: 10.1007/s00405-016-4060-z. Epub 2016 Apr 28. Eur Arch Otorhinolaryngol. 2016. PMID: 27126336 Free PMC article. Clinical Trial.
Ultra-short-course booster allergen immunotherapy.
Pfaar O, Pieper-Fürst U, Mösges R. Pfaar O, et al. Among authors: mosges r. Immunotherapy. 2018 Jun;10(7):525-528. doi: 10.2217/imt-2018-0020. Epub 2018 Mar 22. Immunotherapy. 2018. PMID: 29562789 Free article. No abstract available.
303 results